Source - SMW
The UK's flagship index ended in negative territory on Thursday as the global number of coronavirus cases topped 12 million and US markets followed Europe lower, despite gradual improvements to US jobless claims data.

Adding to the sense of unease was UK Chancellor Rishi Sunak's warning of 'difficult times ahead' in a TV interview. This followed yesterday's summer statement in which Sunak announced a £30bn package of measures to help boost the economy.

The FTSE 100 finished the session down 106.54 points, or 1.73%, at 6,049.62, while the FTSE 250 closed 200.10 points lower at 16,985.10.

LARGE AND MID CAP RISERS AND FALLERS

Rolls-Royce has tumbled 10.2% to 258.4p after it reported a free cash outflow of £3bn in the first half as widebody engine flying hours fell by approximately 75% in the second quarter.

In a trading update for the first half of 2020, the company said cashflows had been 'significantly affected' by Covid-19.

Rio Tinto cheapened 7.5p to £46.05 on the news that it plans to start winding down operations at New Zealand Aluminium Smelters (NZAS) following a strategic review which concluded the business is no longer viable.

It said that NZAS had given Meridian Energy notice to terminate the power contract, which will end in August 2021.

Housebuilder Persimmon climbed 5.9% to £25.76 after it said in a trading update for the first half that sales levels were 'encouraging'.

The company reported that forward sales of new homes reached £1.86bn by 30 June, up 15% on last year and its build programme returned to normal levels.

3i Infrastructure softened 0.5% to 294p as the infrastructure investment company said the performance of its portfolio was in line with expectations as total income declined from April through the end of June.

The company said it would pay a final dividend for 2020 of 4.6p a share on 13 July 2020.

AstraZeneca headed 1.1% lower to £84.82 after the pharma giant said the US Food and Drug Administration had accepted supplemental new drug application and granted priority review for a drug used to reduce subsequent stroke in patients who experienced an acute ischemic stroke or transient ischemic attack.

Building materials distributor Grafton gained 4.3% to 667.25p on the news it remained uncertain about the revenue outlook for the second half of the year as better than anticipated performance in June was likely boosted by pent-up demand.

C&C fizzed up 4.6% to 239.5p on the announcement that it has appointed David Forde as chief executive officer, who has joined from Heineken.

SMALL CAP RISERS AND FALLERS

Staffing firm Robert Walters improved 1.5% to 402p as founder and chief executive Robert Walters said his charge is ready to gain market share when hiring picks up again.

Sports nutrition business Science in Sport sprinted 9.5% higher to 34.5p on news of a surprisingly robust performance first half performance, which included a marked acceleration in the shift to online sales as well as strong growth in the USA.


Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.